I started writing this prior to the market opening today (02012.01.27) and I wanted to post it before the market opened, but I waited because I noticed that our other stem cell stock, Aastrom Biosciences (ASTM), was up in pre-market trading.
At the open on 02012.01.27, ASTM spiked from $2.00 to $2.09 and STEM spiked from $0.90 to $1.02.
In a nutshell (it's a nutshell because it's all I know), it appears as though investors are getting increasingly bullish on how well the stem cell industry can do this year.
No comments:
Post a Comment